These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31576498)

  • 1. Pharmacological management of invasive mold infections in solid organ transplant recipients.
    Fernández-Ruiz M
    Expert Opin Pharmacother; 2024 Feb; 25(3):239-254. PubMed ID: 38436619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Early Fungal Disease in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
    Pennington KM; Martin MJ; Murad MH; Sanborn D; Saddoughi SA; Gerberi D; Peters SG; Razonable RR; Kennedy CC
    Transplantation; 2024 Apr; 108(4):970-984. PubMed ID: 37953478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population-based cohort study.
    Hosseini-Moghaddam SM; Ouédraogo A; Naylor KL; Bota SE; Husain S; Nash DM; Paterson JM
    Transpl Infect Dis; 2020 Apr; 22(2):e13250. PubMed ID: 31981389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
    Lum L; Lee A; Vu M; Strasser S; Davis R
    Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The issue of the antifungal drug choice in prophylaxis of invasive fungal infection after liver transplant.
    Lavezzo B; Romagnoli R; Balagna R; De Rosa FG
    Transpl Infect Dis; 2020 Feb; 22(1):e13220. PubMed ID: 31782237
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes of solid organ transplant recipients with invasive aspergillosis and other mold infections.
    Farges C; Cointault O; Murris M; Lavayssiere L; Lakhdar-Ghazal S; Del Bello A; Hebral AL; Esposito L; Nogier MB; Sallusto F; Iriart X; Charpentier E; Guitard J; Muscari F; Dambrin C; Porte L; Kamar N; Cassaing S; Faguer S
    Transpl Infect Dis; 2020 Feb; 22(1):e13200. PubMed ID: 31630477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients.
    Silva JT; Husain S; Aguado JM
    Transpl Int; 2023; 36():11845. PubMed ID: 38161768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Computed Tomography Characteristics of Solitary Pulmonary Nodules Caused by Fungi: A Comparative Study.
    Jiang J; Lv ZM; Lv FJ; Fu BJ; Liang ZR; Chu ZG
    Infect Drug Resist; 2022; 15():6019-6028. PubMed ID: 36267266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusion of Mucorales Co-Infection in a Patient with
    Kessel J; Hogardt M; Aspacher L; Wichelhaus TA; Gerkrath J; Rosenow E; Springer J; Rickerts V
    J Fungi (Basel); 2022 Mar; 8(3):. PubMed ID: 35330308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?
    Ravindranath MH; El Hilali F; Filippone EJ
    Front Immunol; 2021; 12():667834. PubMed ID: 34880853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Prognosis of Invasive Fungal Disease in Chinese Lung Transplant Recipients.
    Ju C; Lian Q; Xu X; Cao Q; Lan C; Chen R; He J
    Front Med (Lausanne); 2021; 8():718747. PubMed ID: 34778284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors of Invasive Fungal Infection in Recipients After Liver Transplantation: A Systematic Review and Meta-Analysis.
    Liu M; Zhu Z; Sun L
    Front Med (Lausanne); 2021; 8():687028. PubMed ID: 34671611
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on invasive fungal infections in the Middle Eastern and North African region.
    Osman M; Al Bikai A; Rafei R; Mallat H; Dabboussi F; Hamze M
    Braz J Microbiol; 2020 Dec; 51(4):1771-1789. PubMed ID: 32623654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Welcome to our new Section Editors in INFECTION.
    Bogner JR
    Infection; 2020 Feb; 48(1):1-2. PubMed ID: 31919762
    [No Abstract]   [Full Text] [Related]  

  • 15. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response.
    Welte T; Len O; Muñoz P; Romani L; Lewis R; Perrella A
    Infection; 2019 Dec; 47(6):919-927. PubMed ID: 31576498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.
    Neofytos D; Garcia-Vidal C; Lamoth F; Lichtenstern C; Perrella A; Vehreschild JJ
    BMC Infect Dis; 2021 Mar; 21(1):296. PubMed ID: 33761875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis of invasive mould infections and disease.
    Lamoth F; Calandra T
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i19-i28. PubMed ID: 28355464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
    Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.